NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients
Abstract Sclerosing cholangitis in critically ill patients (SC-CIP) is a progressive cholestatic disease of unknown aetiology characterized by chronic biliary infections. Hence we hypothesized that common NOD2 (nucleotide-binding oligomerisation domain containing 2) gene variants, known risk factors...
Guardado en:
Autores principales: | Christoph Jüngst, Vanessa Stadlbauer, Matthias C. Reichert, Vincent Zimmer, Susanne N. Weber, Lisa Ofner-Ziegenfuß, Torsten Voigtländer, Walter Spindelböck, Peter Fickert, Gabriele I. Kirchner, Frank Lammert, Tim O. Lankisch, Marcin Krawczyk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a695bed299964c64a45f7272a191bee3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis
por: Agnieszka Kempinska-Podhorodecka, et al.
Publicado: (2021) -
Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population
por: Mateus Jorge Nardelli, et al.
Publicado: (2021) -
S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.
por: Lisa Reinhard, et al.
Publicado: (2012) -
Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography
por: Rolf Reiter, et al.
Publicado: (2021) -
The Evolution of Very Early Onset Inflammatory Bowel Disease, Autoimmune Hepatitis, and Primary Sclerosing Cholangitis in a Young Girl
por: Aditi Dey, et al.
Publicado: (2021)